Search Tag: Abbott

ICU Management

Abbott-announces-ce-mark-for-its-alinity-s-blood-and-plasma-screening-system

2017 12 Jan

Abbott has announced its Alinity™ s System for blood and plasma screening received CE Mark and is now available in Europe and other countries that recognize CE Mark. The new testing solution is designed to screen blood and plasma faster and more efficiently within a smaller footprint than Abbott's current systems. In a testing specialty that can require extensive...Read more

ICU Management

Establishment-of-ambulatory-emergency-services-at-james-paget-university-hospital

2016 09 Dec

INTRODUCTION   A study of emergency admissions in England found that over a quarter of admissions did not require an overnight stay (length of stay [LoS] of zero). 1  This suggests that many emergency patients could benefit from ambulatory emergency care (AEC). 1   Fundamental to AEC is the identification and management of patients with...Read more

ICU Management

Abbott-to-acquire-alere-becoming-leader-in-point-of-care-testing-advancing-global-diagnostics

2016 18 Feb

ABBOTT GAINS LEADERSHIP IN THE $5.5 BILLION POINT OF CARE SEGMENT, BROADENS DIAGNOSTICS FOOTPRINT AND ENHANCES ACCESS TO FAST-GROWING DIAGNOSTICS CHANNELS - Transaction expected to be immediately accretive to Abbott's ongoing earnings per share upon close - Acquisition will provide access to new product applications, channels and geographies -...Read more

ICU Management

Rapid-pathogen-testing-with-pcr-esi-ms-in-practice

2015 31 Dec

Kristoffer Strålin, MD, PhD , is Associate Professor and Senior Consultant at the Department of Infectious Diseases, Karolinska Institute, Stockholm, Sweden. Karolinska Institute is a world renowned medical university, which has the mission of improving people’s health through research and education. Together with Karolinska University Hospital,...Read more

ICU Management

Innovation-to-id-infection-source-without-blood-culture

2014 16 Sep

A new study suggests a pioneering testing technology could reduce hospital stays by up to eight days and lower annual health care costs for people with serious infections by approximately  $2.2 million  (€1.5 million / £1.2 million).[1] The cost reductions are based on a health economic model from the RApid Diagnosis of Infections in the CriticAlly...Read more

ICU Management

Oral-nutritional-supplements-in-the-hospital-demonstrate-significant-health-cost-benefits

2013 04 Sep

A recent health economics and outcomes study, conducted by leading health economists and supported by Abbott, found that oral nutritional supplements provided to patients during hospitalization were associated with significant reductions in length of stay and hospitalization cost. Additionally, the 30-day readmission risk was significantly reduced for...Read more

ICU Management

New-data-for-abbott-s-high-sensitive-troponin-test-shows-it-may-predict-heart-attack-risk

2013 01 Aug

Abbott announced on July 30, 2013, promising results from a study evaluating its High Sensitive Troponin-I (hsTnI) assay presented at this year’s American Association for Clinical Chemistry (AACC) annual meeting in Houston, Texas. The study, conducted by researchers at Brigham and Women’s Hospital, demonstrated that Abbott’s hsTnI test (currently...Read more

ICU Management

Abbott-previews-next-generation-blood-screening-prototype-during-isbt-meeting-in-amsterdam

2013 04 Jun

Abbott previewed a prototype for the company’s next-generation blood screening system at an event coinciding with this year’s International Society of Blood Transfusion (ISBT) Meeting in Amsterdam from June 2-5, 2013. Abbott’s new system features a user-responsive design based upon insights provided by leading blood screening experts from around the...Read more